INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 26 filers reported holding INMUNE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,545 | -43.4% | 8,500 | -24.1% | 0.00% | – |
| Q2 2023 | $101,696 | +98.4% | 11,200 | +41.1% | 0.00% | – |
| Q1 2023 | $51,260 | -13.1% | 7,935 | -14.2% | 0.00% | – |
| Q4 2022 | $59,000 | +55.3% | 9,250 | +52.9% | 0.00% | – |
| Q3 2022 | $38,000 | -22.4% | 6,050 | +8.9% | 0.00% | – |
| Q2 2022 | $49,000 | -82.4% | 5,557 | -83.2% | 0.00% | -100.0% |
| Q1 2022 | $279,000 | -23.4% | 33,100 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $364,000 | +53.6% | 35,738 | +193.7% | 0.00% | – |
| Q3 2021 | $237,000 | -50.5% | 12,170 | -55.4% | 0.00% | -100.0% |
| Q2 2021 | $479,000 | +409.6% | 27,262 | +241.5% | 0.00% | – |
| Q1 2021 | $94,000 | -8.7% | 7,982 | +33.0% | 0.00% | – |
| Q4 2020 | $103,000 | +66.1% | 6,000 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | +6100.0% | 6,000 | +2900.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 200 | -33.3% | 0.00% | – |
| Q1 2020 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
| Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
| Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
| YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
| Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
| Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
| FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
| Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
| Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |